GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » COGS-to-Revenue

Hubei Guangji Pharmaceutical Co (SZSE:000952) COGS-to-Revenue : 0.81 (As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Hubei Guangji Pharmaceutical Co COGS-to-Revenue?

Hubei Guangji Pharmaceutical Co's Cost of Goods Sold for the three months ended in Sep. 2024 was ¥133.8 Mil. Its Revenue for the three months ended in Sep. 2024 was ¥165.7 Mil.

Hubei Guangji Pharmaceutical Co's COGS to Revenue for the three months ended in Sep. 2024 was 0.81.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Hubei Guangji Pharmaceutical Co's Gross Margin % for the three months ended in Sep. 2024 was 19.27%.

Hubei Guangji Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Hubei Guangji Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Guangji Pharmaceutical Co COGS-to-Revenue Chart

Hubei Guangji Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 0.59 0.62 0.63 0.73

Hubei Guangji Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.76 0.84 0.61 0.81

Hubei Guangji Pharmaceutical Co COGS-to-Revenue Calculation

Hubei Guangji Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=535.62 / 737.819
=0.73

Hubei Guangji Pharmaceutical Co's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=133.793 / 165.738
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Guangji Pharmaceutical Co  (SZSE:000952) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Hubei Guangji Pharmaceutical Co's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 133.793 / 165.738
=19.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Hubei Guangji Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hubei Guangji Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Guangji Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » COGS-to-Revenue
Comparable Companies
SZSE:000705 SHSE:600671 SZSE:001367 SZSE:301281 SHSE:600613 SZSE:002198 SZSE:300006 SZSE:000908 SZSE:301096 SZSE:301507 LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN
Traded in Other Exchanges
N/A
Address
No. 1 Jiangdi Road, Hubei, Wuxue, CHN, 435400
Website
http://www.guangjipharm.com
Hubei Guangji Pharmaceutical Co Ltd is engaged in the manufacture and sale of raw pharmaceutical products, medicinal feed additives, fine chemicals and preparations in China. Geographically the business activities are carried out through China, however, more than 60 percent of its main products are exported to over 30 countries and regions all over the world.
Executives
Zou Guang Ming Independent director
Guo Shao Zhi Executives
Zhang Bin Director
Guo Wen Chao Supervisors
Sun Zhen Hua Director
Liao Qing Jiang Director
Wang Xin Directors, executives
Hu Feng Lei Supervisors
Ruan Zhong Yi Executives
Zhang Ping Director

Hubei Guangji Pharmaceutical Co Headlines

No Headlines